NTAGI meeting on Vaccination of 5-12 years Inconclusive

Share Us

735
NTAGI meeting on Vaccination of 5-12 years Inconclusive
05 May 2022
min read

News Synopsis

According to sources, the National Technical Advisory Group on Immunization (NTAGI), an Indian vaccine think tank, met to discuss immunization protocols for 5-12-years-old children but did not bring to any conclusion.

Members of NTAGI reviewed data from vaccine manufacturers for 5-12-year-old children but no decision regarding the expansion of the program to the younger group was taken.

Last month, regulatory agencies approved two vaccines for use in 5-12-year-old children, Serum Institute's Covovax and Biological E-made Corbevax. However, the NTAGI will decide on whether these would be used in India’s Covid-19 vaccination program. 

TWN In-Focus